|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8500 USD | +3.24% |
|
+31.78% | +70.00% |
| 05-14 | Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 | CI |
| 04-07 | Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
Company Valuation: Cell Source, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 29.13 | 63.92 | 43.22 | 29.96 | 17.95 | 15.26 |
| Change | - | 119.45% | -32.39% | -30.67% | -40.09% | -14.98% |
| Enterprise Value (EV) 1 | 31.8 | 68.58 | 49.62 | 37.65 | 27.22 | 25.77 |
| Change | - | 115.68% | -27.64% | -24.14% | -27.68% | -5.35% |
| P/E | -5.97x | -10.7x | -6.58x | -4.68x | -2.65x | -2.49x |
| PBR | -5.19x | -8.19x | -4.48x | -2.43x | -1.17x | -0.85x |
| PEG | - | -7.3x | -1.59x | 0.7x | 0.58x | 0.1x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -8.36x | -18.9x | -12.3x | -9.02x | -6.51x | -6.71x |
| EV / FCF | -39.4x | -44.2x | -22.8x | -28.2x | -26.2x | -37.4x |
| FCF Yield | -2.54% | -2.26% | -4.38% | -3.55% | -3.82% | -2.68% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.1842 | -0.1869 | -0.1946 | -0.1816 | -0.1733 | -0.1406 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -3.805 | -3.638 | -4.019 | -4.175 | -4.183 | -3.84 |
| Net income 1 | -4.475 | -4.56 | -5.472 | -5.168 | -5.321 | -4.513 |
| Net Debt 1 | 2.67 | 4.661 | 6.404 | 7.682 | 9.274 | 10.51 |
| Reference price 2 | 1.1000 | 2.0000 | 1.2805 | 0.8500 | 0.4600 | 0.3500 |
| Nbr of stocks (in thousands) | 26,479 | 31,960 | 33,752 | 35,252 | 39,022 | 43,602 |
| Announcement Date | 3/30/20 | 4/15/21 | 4/15/22 | 8/8/23 | 6/24/24 | 4/7/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 55.94M | |
| 32.44x | 8.02x | 24.72x | 0.05% | 55.01B | |
| 20.35x | 6.27x | 13.72x | 1.56% | 54.24B | |
| -18.46x | 4.46x | -7.81x | -.--% | 23.38B | |
| -40.77x | 12.94x | -38.12x | -.--% | 22.57B | |
| 25.4x | 4.97x | 13.15x | -.--% | 20.19B | |
| 24.92x | 4.83x | 15.71x | -.--% | 17.86B | |
| -778.79x | 36.99x | -4163.86x | -.--% | 15.5B | |
| 42.81x | 17.28x | 44.49x | 0.09% | 14.2B | |
| 17.78x | 5.16x | 12.03x | -.--% | 14.2B | |
| Average | -74.92x | 11.21x | -454.00x | 0.19% | 23.72B | |
| Weighted average by Cap. | -36.76x | 9.51x | -261.99x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CLCS Stock
- Valuation Cell Source, Inc.
Select your edition
All financial news and data tailored to specific country editions
